Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A patient developed a blister at the injection site after hepatitis C treatment.

Certain medications can cause serious side effects, so it's important to report them.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Various drugs caused different skin reactions, including allergic and inflammatory responses.